Pyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-diones: Synthesis, Cyclometalation, and Protein Kinase Inhibition

Abstract

Synthetic routes to pyrido[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-diones are disclosed and examples for their subsequent transformations into cyclometalated protein kinase inhibitors are presented.

pyridocarbazoles - photocyclization - cyclometalation - ruthenium - protein kinase inhibitors

References

For metal-based drugs, see:

1a Chem. Rev.   Vol. 99:  Orvig C. Abrams MJ. American Chemical Society; Washington DC: 1999.  p.2201 

1b Guo Z. Sadler PJ. Angew. Chem. Int. Ed.  1999,  38:  1512 

1c Coord. Chem. Rev.   Vol. 232:  Farrell N. Elsevier; Amsterdam: 2002.  p.1 

For bioorganometallic chemistry, see:

2a Severin K. Bergs R. Beck W. Angew. Chem. Int. Ed.  1998,  37:  1634 

2b Grotjahn DB. Coord. Chem. Rev.  1999,  190:  1125 

2c J. Organomet. Chem.   Vol. 589:  Jaouen G. Elsevier; Amsterdam: 1999.  p.1 

2d Metzler-Nolte N. Angew. Chem. Int. Ed.  2001,  40:  1040 

2e Fish RH. Jaouen G. Organometallics  2003,  22:  2166 

3 Metal complexes as enzyme inhibitors: Louie AY. Meade TJ. Chem. Rev.  1999,  99:  2711 

4 Zhang L. Carroll PJ. Meggers E. Org. Lett.  2004,  6:  521 

5 Bregman H. Willams DS. Atilla E. Carroll PJ. Meggers E. J. Am. Chem. Soc.  2004,  126:  13594 

6a Toledo LM. Lydon NB. Structure  1997,  1551 

6b Lawrie AM. Noble MEM. Tunnah P. Brown NR. Johnson LN. Endicott JA. Nat. Struct. Biol.  1997,  796 

7 Taylor SS. Radzio-Andzelm E. Curr. Opin. Chem. Biol.  1997,  219 

8a Faul MM. Winneroski LL. Krumrich CA. J. Org. Chem.  1998,  63:  6053 

8b Faul MM. Winneroski LL. Krumrich CA. Tetrahedron Lett.  1999,  40:  1109 

8c Sanchez-Martinez C. Faul MM. Shih C. Sullivan KA. Grutsch JL. Cooper JT. Kolis SP. J. Org. Chem.  2003,  68:  8008 

9a Berlinck RGS. Britton R. Piers E. Lim L. Roberge M. Moreira da Roche R. Andersen RJ. J. Org. Chem.  1998,  63:  9850 

9b Piers E. Britton R. Andersen RJ. J. Org. Chem.  2000,  65:  530 

For the analogous synthesis of some pyridyl, quinolinyl, and isoquinolinyl[a]pyrrolo[3,4-c]carbazoles, see:

10a Zhu G. Conner S. Zhou X. Shih C. Brooks HB. Considine E. Dempsey JA. Ogg C. Patel B. Schultz RM. Spencer CD. Teichner B. Watkins SA. Bioorg. Med. Chem. Lett.  2003,  13:  1231 

10b Sanchez-Martinez C. Shih C. Faul MM. Zhu G. Paal M. Somoza C. Li T. Kumrich CA. Winneroski LL. Xun Z. Brooks HB. Patel BKR. Schultz RM. DeHahn TB. Spencer CD. Watkins SA. Considine E. Dempsey JA. Ogg CA. Campbell RM. Anderson BA. Wagner J. Bioorg. Med. Chem. Lett.  2003,  13:  3835 

11 Kita Y. Haruta J. Fujii T. Segwawa J. Synthesis  1981,  451 

12 Thummel RP. Hegde V. J. Org. Chem.  1989,  54:  1720 

13 Ohkubo M. Nishimura T. Jona H. Honma T. Morishima H. Tetrahedron  1996,  52:  8099 

A related approach was used to synthesize granulatimides:

14a Yoshida T. Nishiyachi M. Nakashima N. Murase M. Kotani E. Chem. Pharm. Bull.  2002,  50:  872 

14b Yoshida T. Nishiyachi M. Nakashima N. Murase M. Kotani E. Chem. Pharm. Bull.  2003,  51:  209 

15 Qinde L. Mudadu MS. Schmider H. Thummel R. Tao Y. Wang S. Organometallics  2002,  21:  4743 

16 Legros J.-Y. Primault G. Fiaud J.-C. Tetrahedron  2001,  57:  2507 

17 Gill TP. Mann KR. Organometallics  1982,  1:  485 

18 Rüba E. Mereiter K. Soldouzi KM. Gemel C. Schmid R. Kirchner K. Bustelo E. Puerta MC. Valerga P. Organometallics  2000,  19:  5384 

19 Williams DS. Atilla GE. Bregman H. Arzoumanian A. Klein PS. Meggers E. Angew. Chem. Int. Ed.  2005,  44:  1984